
Loading, please wait...

Loading, please wait...

India recently launched its national HPV vaccination campaign to combat cervical cancer among adolescent girls. Prime Minister Narendra Modi inaugurated the initiative in Ajmer, Rajasthan. This landmark step reflects India's strong commitment to women's health. Consequently, the World Health Organization (WHO) congratulated the nation on this massive public health milestone. The move signals a decisive shift in the country's public health journey.
The program targets approximately 1.15 crore girls aged 14 every year. Therefore, it aims to reduce the heavy burden of cervical cancer in the region significantly. Currently, cervical cancer claims a woman's life every two minutes globally. India carries nearly one-quarter of this global burden. Specifically, the government will provide the vaccine free of cost at designated facilities. This ensures equity and protection for all daughters of the country.
Furthermore, this rollout aligns with the global 90-70-90 targets for 2030. These targets involve vaccinating 90% of girls by age 15. Additionally, they include screening 70% of women twice by ages 35 and 45. Finally, 90% of women with cervical disease must receive appropriate treatment. India's effort will accelerate regional momentum toward eliminating this disease as a public health problem.
Q1: Who is the target audience for the HPV vaccination campaign?
The campaign primarily targets approximately 1.15 crore girls aged 14 years across all States and Union Territories annually.
Q2: Is the HPV vaccine provided for free in India?
Yes, the vaccine is provided free of cost at designated Government health facilities as part of this national initiative.
Q3: What are the WHO 90-70-90 targets mentioned?
The 2030 targets aim to vaccinate 90% of girls by age 15, screen 70% of women, and treat 90% of those with cervical cancer or pre-cancer.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


India launches a national HPV vaccination campaign targeting 1.15 crore girls annually to eliminate cervical cancer and meet WHO global targets by 2030....
5 months ago

Personalized medicine requires novel reimbursement models. This review examines how indication-based and performance-based pricing schemes influence drug availability, patient equity, and health system sustainability across multi-indication therapies.
Today

A retrospective cohort study reveals that simulation-free vaginal cuff brachytherapy achieves low 5-year vaginal recurrence rates comparable to simulation-verified protocols in high-intermediate risk endometrial cancer, supporting streamlined radiation oncology workflows.
Today

A newly reported de novo WAC frameshift variant expands the electroclinical and systemic phenotype of DeSanto-Shinawi syndrome, highlighting temporo-occipital epileptiform discharges alongside congenital heart anomalies.
Today

A breakthrough study reveals how the agricultural fungicide thiram disrupts hepatic and tibial calcium homeostasis through ER stress and IP3R1/VDAC1 hyperactivation, uncovering a critical liver-bone axis of systemic toxicity.
Today

A study in children with severe acute malnutrition reveals disordered pancreatic and gut hormone responses to nutrient stimulation, including elevated basal insulin and blunted postprandial surges. These findings emphasize the need for refined nutritional rehabilitation protocols to prevent metabolic complications.
Today